These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12698873)

  • 1. Recent advances in the understanding of the induction and regulation of mucosal inflammation.
    Strober W; Fuss IJ; Nakamura K; Kitani A
    J Gastroenterol; 2003 Mar; 38 Suppl 15():55-8. PubMed ID: 12698873
    [No Abstract]   [Full Text] [Related]  

  • 2. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.
    Khalil PN; Weiler V; Nelson PJ; Khalil MN; Moosmann S; Mutschler WE; Siebeck M; Huss R
    Gastroenterology; 2007 Mar; 132(3):944-54. PubMed ID: 17383423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Animal models of intestinal inflammation].
    Morteau O; Bueno L
    Gastroenterol Clin Biol; 1995 Feb; 19(2):204-14. PubMed ID: 7750711
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression signatures, barriers and beyond: the role of oxidative stress in murine colitis and human inflammatory bowel disease revisited.
    Rosenstiel P; Schreiber S
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):496-9. PubMed ID: 18467906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking.
    Chin AC; Parkos CA
    Ann N Y Acad Sci; 2006 Aug; 1072():276-87. PubMed ID: 17057207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of inflammatory bowel disease: lessons from enteric infections.
    Eckmann L
    Ann N Y Acad Sci; 2006 Aug; 1072():28-38. PubMed ID: 17057188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation.
    Brun P; Mastrotto C; Beggiao E; Stefani A; Barzon L; Sturniolo GC; Palù G; Castagliuolo I
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G621-9. PubMed ID: 15764810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of detoxification in inflammatory bowel disease.
    Langmann T; Schmitz G
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):358-9. PubMed ID: 16819479
    [No Abstract]   [Full Text] [Related]  

  • 14. Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease.
    Powrie F; Uhlig H
    Novartis Found Symp; 2004; 263():164-74; discussion 174-8, 211-8. PubMed ID: 15669641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial influences in inflammatory bowel diseases.
    Sartor RB
    Gastroenterology; 2008 Feb; 134(2):577-94. PubMed ID: 18242222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of innate immunity in the development of inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Tucková L; Stepánková R; Hudcovic T; Palová-Jelínková L; Kozáková H; Rossmann P; Sanchez D; Cinová J; Hrncír T; Kverka M; Frolová L; Uhlig H; Powrie F; Bland P
    Ann N Y Acad Sci; 2005 Jun; 1051():787-98. PubMed ID: 16127016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models of inflammatory bowel disease.
    Wirtz S; Neurath MF
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1073-83. PubMed ID: 17825455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine network in inflammatory bowel disease.
    Fuss IJ
    Curr Drug Targets Inflamm Allergy; 2003 Jun; 2(2):101-12. PubMed ID: 14561161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 modulates intestinal injury in rats with transmural colitis.
    Medina C; Santana A; Paz MC; Díaz-Gonzalez F; Farre E; Salas A; Radomski MW; Quintero E
    J Leukoc Biol; 2006 May; 79(5):954-62. PubMed ID: 16478919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.